ELEVANCE HEALTH REPORTS THIRD QUARTER 2026 RESULTS
Revenue$50.4 billion+0.7% YoY
EPS$6.27
Outlookraisedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.